Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology

ASCO provides a summary of issues and recommendations related to the 340B program for policymakers to consider from the perspective of professionals dedicated to the prevention, diagnosis and treatment of cancer.

No comments have been posted yet.